SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-118340
Filing Date
2024-04-26
Accepted
2024-04-26 17:05:31
Documents
19
Period of Report
2024-04-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d813820d8k.htm   iXBRL 8-K 32770
2 EX-1.1 d813820dex11.htm EX-1.1 194786
3 EX-4.1 d813820dex41.htm EX-4.1 59626
4 EX-4.2 d813820dex42.htm EX-4.2 84396
5 EX-5.1 d813820dex51.htm EX-5.1 10473
6 EX-99.1 d813820dex991.htm EX-99.1 8251
10 GRAPHIC g813820dsp009.jpg GRAPHIC 4071
  Complete submission text file 0001193125-24-118340.txt   628787

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA vinc-20240425.xsd EX-101.SCH 2839
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vinc-20240425_lab.xml EX-101.LAB 18738
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vinc-20240425_pre.xml EX-101.PRE 11700
22 EXTRACTED XBRL INSTANCE DOCUMENT d813820d8k_htm.xml XML 3767
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39244 | Film No.: 24885051
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)